Novartis | NOVN - Dywidenda Wydajność





Dy Zmiana Data
AbbVie 3.1 0.19 2026-03
Alcon AG USD 0.52 0.09 2026-03
Amgen 2.78 0.17 2026-03
AstraZeneca USD 1.18 0.56 2026-03
Bayer 0.28 0.02 2026-03
Bristol-Myers Squibb 4.12 3.9 2026-03
Eli Lilly 0.58 0.16 2025-12
Fresenius 2.04 0.07 2025-12
Fresenius Medical Care 3.86 0.33 2026-03
Genmab 0 0 2025-03
Gilead Sciences 2.29 0.29 2026-03
GlaxoSmithKline 0.82 3.75 2026-03
GRIFOLS 2.21 0.29 2026-03
Hikma Pharmaceutical USD 4.02 1.1 2025-12
J&J 2.16 0.34 2026-03
Lakefront Biotherapeutics 0 0 2025-03
Lonza 0.74 0.04 2025-12
Merck 2.04 0.25 2026-03
Merck 2.76 0.36 2026-03
Novartis USD 3.33 0.29 2026-03
Novartis 2.9 0.22 2025-12
Novo Nordisk 5.07 1.54 2026-03
Orion 2.59 0.06 2026-03
Pfizer 6.36 0.55 2026-03
Philips 3.99 0.36 2025-06
Recordati 2.73 0.06 2026-03
Regeneron Pharmaceuticals 0.46 0.01 2026-03
Roche Holding 2.96 0.8 2025-12
Sanofi 4.98 0.24 2026-03
UCB 0.58 0.25 2025-12